local
FDA panel on peptides will include experts who promote the unproven chemicals favored by RFK Jr.
By Matthew Perrone, Associated Press at KSAT 12 (ABC affiliate)
· June 29, 2026
· 5 min read
When U.S. health officials meet next month to reconsider a list of controversial peptide drugs, they will hear from a new set of voices: doctors and pharmacists with deep financial ties to the burgeoning industry of unproven chemicals.The Food and Drug Administration on Monday released its list o...
Key takeaway Previous FDA panels on the topic have been composed of academics and researchers.
Why this matters in The San Antonio
San Antonio residents who have seen peptide clinics and wellness centers pop up around the city may be interested to know that the FDA's upcoming meeting on peptide safety will feature a panel with deep financial ties to the industry. This shift in the panel's composition could have significant implications for the local health and wellness scene, where peptides are often marketed as a means to build muscle and heal injuries. As the FDA reconsiders the safety and effectiveness of these substances, San Antonio's own compounding pharmacies and wellness clinics will be watching closely, given their role in producing and promoting peptide formulas. The city's athletes and individuals seeking alternative wellness treatments should also be aware of the potential risks associated with these unproven chemicals, which have been warned against by the FDA for several years.
About this story
Original reporting by KSAT 12 (ABC affiliate) . The San Antonio surfaces reporting from trusted publishers and adds local editorial context so readers can quickly understand what a story means for their community. We attribute every source, link to the original report, and follow a documented editorial standards policy. To understand how stories are selected and reviewed, read our about page .
For the complete original report, visit KSAT 12 (ABC affiliate) . Have a tip or correction? Contact our newsroom .
Category: local ·
Published: June 29, 2026 ·
Source: KSAT 12 (ABC affiliate) ·
Reading time: 5 min
Get more The San Antonio stories like this
Free weekly briefing covering local and other local news. Curated by our editorial team. No spam.
By subscribing you agree to our privacy policy . Unsubscribe anytime.
Frequently asked about this story
What is this story about? When U.S. health officials meet next month to reconsider a list of controversial peptide drugs, they will hear from a new set of voices: doctors and pharmacists with deep financial ties to the burgeoning industry of unproven chemicals.The Food and Drug Administration on Monday released its list o...
When was this published? This article was first published on June 29, 2026 by KSAT 12 (ABC affiliate) and curated for The San Antonio readers.
Who reported this story? This story was reported by Matthew Perrone, Associated Press at KSAT 12 (ABC affiliate). To learn more about how The San Antonio selects and reviews stories, see our editorial standards .
Where can I find related coverage? See more local coverage from The San Antonio, or browse our daily briefing and topic hubs .
← Back to all news
More local →
Today’s briefing
Subscribe to newsletter